Samsung Bioepis ventures into novel R&D with Takeda deal
admin 22nd August 2017 Uncategorised 0Samsung Bioepis is joining forces with Takeda Pharmaceutical to jointly fund and co-develop multiple novel biologic therapies in unmet disease areas, taking its first step towards developing new pharmaceuticals.
More: Samsung Bioepis ventures into novel R&D with Takeda deal
Source: News